VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-7.72 Cr | ₹-4.24 Cr | ₹-1.99 Cr | ₹-0.90 Cr | ₹-0.44 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VIMTA LABS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-7.72 Cr |
Mar2023 | ₹-4.24 Cr |
Mar2022 | ₹-1.99 Cr |
Mar2021 | ₹-0.90 Cr |
Mar2020 | ₹-0.44 Cr |
How is Deferred Tax Assets / Liabilities of VIMTA LABS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-7.72 Cr | Negative | |
Mar2023 | ₹-4.24 Cr | Negative | |
Mar2022 | ₹-1.99 Cr | Negative | |
Mar2021 | ₹-0.90 Cr | Negative | |
Mar2020 | ₹-0.44 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹1,939.5 Cr | -13.4% | -4.9% | 84.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,188.0 Cr | -1.5% | 4.6% | 3% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,074.0 Cr | -4.8% | -3.2% | 40.7% | Stock Analytics | |
CIPLA | ₹115,768.0 Cr | -1.3% | -1.9% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,809.0 Cr | 1.1% | 6.1% | 27.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,503.5 Cr | -3.6% | -2.7% | -11.4% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | -13.4% |
-4.9% |
84.1% |
SENSEX | -2.4% |
0.7% |
0.5% |
You may also like the below Video Courses